Table 1 Parameters comparison between the sham and dyslipidemia groups
Variables | Sham (n = 10) | Control (n = 10) | Atorvastatin (n = 10) | PUFA (n = 10) | Combined (n = 10) |
|---|---|---|---|---|---|
At initial | |||||
TG (mmol/L) | 1.08 ± 0.11 | 1.03 ± 0.12 | 1.04 ± 0.10 | 1.06 ± 0.11 | 1.04 ± 0.12 |
TC (mmol/L) | 3.82 ± 0.21 | 3.80 ± 0.16 | 3.81 ± 0.17 | 3.78 ± 0.16 | 3.78 ± 0.14 |
LDL-C (mmol/L) | 2.03 ± 0.15 | 1.98 ± 0.12 | 2.01 ± 0.12 | 2.00 ± 0.12 | 2.01 ± 0.13 |
HDL-C (mmol/L) | 0.92 ± 0.06 | 0.92 ± 0.05 | 0.93 ± 0.07 | 0.91 ± 0.03 | 0.90 ± 0.07 |
NO (μmol/L) | 12.24 ± 1.23 | 12.09 ± 1.16 | 12.13 ± 1.17 | 12.20 ± 1.09 | 12.12 ± 1.18 |
CRP (mg/L) | 2.08 ± 0.36 | 2.11 ± 0.23 | 2.04 ± 0.29 | 2.10 ± 0.19 | 2.11 ± 0.24 |
sVCAM (μg/mL) | 3.52 ± 0.26 | 3.57 ± 0.33 | 3.49 ± 0.20 | 3.50 ± 0.30 | 3.52 ± 0.35 |
sICAM (μg/mL) | 0.43 ± 0.06 | 0.41 ± 0.03 | 0.44 ± 0.05 | 0.43 ± 0.05 | 0.42 ± 0.05 |
MDA (nmol/L) | 0.86 ± 0.05 | 0.89 ± 0.05 | 0.82 ± 0.04 | 0.86 ± 0.07 | 0.85 ± 0.04 |
1 week of atherogenic diet treatment | |||||
TG (mmol/L) | 1.10 ± 0.12* | 1.23 ± 0.18 | 1.24 ± 0.13 | 1.20 ± 0.09 | 1.22 ± 0.06 |
TC (mmol/L) | 3.85 ± 0.20* | 4.35 ± 0.13 | 4.40 ± 0.17 | 4.41 ± 0.12 | 4.38 ± 0.11 |
LDL-C (mmol/L) | 2.06 ± 0.12* | 2.35 ± 0.26 | 2.32 ± 0.32 | 2.30 ± 0.26 | 2.30 ± 0.21 |
HDL-C (mmol/L) | 0.93 ± 0.06 | 0.90 ± 0.06 | 0.90 ± 0.07 | 0.91 ± 0.03 | 0.92 ± 0.05 |
NO (μmol/L) | 12.18 ± 1.09* | 9.26 ± 1.02 | 9.23 ± 1.06 | 9.25 ± 1.02 | 9.20 ± 1.07 |
CRP (mg/L) | 2.07 ± 0.32* | 4.63 ± 0.43 | 4.61 ± 0.34 | 4.58 ± 0.30 | 4.60 ± 0.26 |
sVCAM (μg/mL) | 3.50 ± 0.25* | 4.95 ± 0.42 | 4.92 ± 0.36 | 4.92 ± 0.18 | 4.93 ± 0.27 |
sICAM (μg/mL) | 0.44 ± 0.05* | 0.58 ± 0.07 | 0.56 ± 0.06 | 0.63 ± 0.08 | 0.65 ± 0.06 |
MDA (nmol/L) | 0.88 ± 0.04* | 1.09 ± 0.06 | 1.05 ± 0.04 | 1.07 ± 0.04 | 1.07 ± 0.06 |